Boston Scientific Spins Out TriVascular AAA Biz To Investors For $30 Mil.

Boston Scientific's reversal of its April 2005 acquisition of endovascular aortic aneurysm repair device developer TriVascular puts the newly independent entity back in the hands of its original management team in exchange for $30 million and a minority equity stake